Press release

Business Wire3 May 2026

Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis on May 4, 2026

FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that it will host an…
Read More »
Business Wire3 May 2026

UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for…
Read More »
Press Release

Cision PR Newswire3 May 2026

Sandhills Medical Foundation, Inc., d/b/a Sandhills Medical Data Breach: Edelson Lechtzin LLP Launches Investigation into Exposure of Personal Information

National class action firm offering free case evaluations to individuals impacted by the Sandhills Medical cybersecurity incident MCBEE, S.C., May…
Read More »
Press Release

Cision PR Newswire3 May 2026

New First-in-Class Therapy for Chronic Graft-Versus-Host Disease Approved in Australia[1]

NIKTIMVO® (axatilimab) approved by the Therapeutic Goods Administration (TGA) under Priority Review for the treatment of eligible Australian patients with…
Read More »
Business Wire3 May 2026

A World Reshaped by Disruption. A Conference Built to Respond

The Milken Institute convenes its 29th annual Global Conference in Los Angeles, May 3–6 LOS ANGELES–(BUSINESS WIRE)–The Milken Institute’s 29th…
Read More »
Business Wire3 May 2026

A World Reshaped by Disruption. A Conference Built to Respond

The Milken Institute convenes its 29th annual Global Conference in Los Angeles, May 3–6 LOS ANGELES–(BUSINESS WIRE)–The Milken Institute’s 29th…
Read More »
Business Wire3 May 2026

A World Reshaped by Disruption. A Conference Built to Respond

The Milken Institute convenes its 29th annual Global Conference in Los Angeles, May 3–6 LOS ANGELES–(BUSINESS WIRE)–The Milken Institute’s 29th…
Read More »
Press Release

Cision PR Newswire3 May 2026

TURPAZ INDUSTRIES ACQUIRES U.S. FLAVOR AND FRAGRANCE COMPANY PHOENIX FOR $95 MILLION

Acquisition Establishes Full-Scale U.S. Operational Platform; Combination with Turpaz’s Existing Klabin Operations Expected to Drive Significant Synergies CAESAREA, Israel, May…
Read More »
Cision PR Newswire3 May 2026

Everads Announces Publication of First-in-Human Clinical Data for Its Suprachoroidal Injector in Ophthalmology Science and Three Presentations at ARVO 2026

– Publication reports favorable safety, tolerability, and device performance, while highlighting posteriorly directed drug distribution as visualized by thermal imaging…
Read More »
Press Release

Cision PR Newswire3 May 2026

139th Canton Fair Phase 3 Advances Toward a Better Life with New and Strengthened Product Zones

GUANGZHOU, China, May 3, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has rolled out nine…
Read More »

Previous page Next page